0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI for Clinical and Molecular Diagnostics Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-14A18632
Home | Market Reports | Science
Global AI for Clinical and Molecular Diagnostics Market Research Report 2024
BUY CHAPTERS

Global AI for Clinical and Molecular Diagnostics Market Research Report 2024

Code: QYRE-Auto-14A18632
Report
November 2024
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI for Clinical and Molecular Diagnostics Market Size

The global AI for Clinical and Molecular Diagnostics market was valued at US$ 2057 million in 2023 and is anticipated to reach US$ 10410 million by 2030, witnessing a CAGR of 25.9% during the forecast period 2024-2030.

AI for Clinical and Molecular Diagnostics Market

AI for Clinical and Molecular Diagnostics Market

AI for clinical and molecular diagnosis refers to the application of artificial intelligence technology in the fields of clinical diagnosis and molecular diagnosis to improve the accuracy, efficiency and personalization of diagnosis. In clinical diagnosis, artificial intelligence can assist doctors in diagnosing diseases by analyzing multi-dimensional data such as patients' medical history, symptoms, physical examination results, and medical images. In addition, artificial intelligence can also provide personalized treatment plan recommendations based on individual differences of patients to achieve precision medicine. In molecular diagnosis, the application of artificial intelligence is more in-depth. Through machine learning algorithms, artificial intelligence can efficiently analyze massive amounts of biological information such as gene sequences and protein structures, thereby revealing the molecular mechanism of the disease. This not only helps to detect diseases early, but also provides new ideas and methods for the prevention and treatment of diseases.
North American market for AI for Clinical and Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for AI for Clinical and Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for AI for Clinical and Molecular Diagnostics in Clinical Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of AI for Clinical and Molecular Diagnostics include Roche, Fujifilm, Illumina, GE HealthCare, Philips, Medtronic, Microsoft, Siemens Healthineers, Intel, Enlitic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI for Clinical and Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI for Clinical and Molecular Diagnostics.
The AI for Clinical and Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI for Clinical and Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI for Clinical and Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of AI for Clinical and Molecular Diagnostics Market Report

Report Metric Details
Report Name AI for Clinical and Molecular Diagnostics Market
Accounted market size in 2023 US$ 2057 million
Forecasted market size in 2030 US$ 10410 million
CAGR 25.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Software
  • Services
  • Hardware
Segment by Application
  • Clinical Diagnostics
  • Molecular Diagnostics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Fujifilm, Illumina, GE HealthCare, Philips, Medtronic, Microsoft, Siemens Healthineers, Intel, Enlitic, NVIDIA, Qure AI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of AI for Clinical and Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is AI for Clinical and Molecular Diagnostics Market growing?

Ans: The AI for Clinical and Molecular Diagnostics Market witnessing a CAGR of 25.9% during the forecast period 2024-2030.

What is the AI for Clinical and Molecular Diagnostics Market size in 2030?

Ans: The AI for Clinical and Molecular Diagnostics Market size in 2030 will be US$ 10410 million.

Who are the main players in the AI for Clinical and Molecular Diagnostics Market report?

Ans: The main players in the AI for Clinical and Molecular Diagnostics Market are Roche, Fujifilm, Illumina, GE HealthCare, Philips, Medtronic, Microsoft, Siemens Healthineers, Intel, Enlitic, NVIDIA, Qure AI

What are the Application segmentation covered in the AI for Clinical and Molecular Diagnostics Market report?

Ans: The Applications covered in the AI for Clinical and Molecular Diagnostics Market report are Clinical Diagnostics, Molecular Diagnostics

What are the Type segmentation covered in the AI for Clinical and Molecular Diagnostics Market report?

Ans: The Types covered in the AI for Clinical and Molecular Diagnostics Market report are Software, Services, Hardware

Recommended Reports

AI Diagnostics Markets

Molecular Diagnostics

Clinical Lab Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Software
1.2.3 Services
1.2.4 Hardware
1.3 Market by Application
1.3.1 Global AI for Clinical and Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Diagnostics
1.3.3 Molecular Diagnostics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI for Clinical and Molecular Diagnostics Market Perspective (2019-2030)
2.2 Global AI for Clinical and Molecular Diagnostics Growth Trends by Region
2.2.1 Global AI for Clinical and Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI for Clinical and Molecular Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 AI for Clinical and Molecular Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 AI for Clinical and Molecular Diagnostics Market Dynamics
2.3.1 AI for Clinical and Molecular Diagnostics Industry Trends
2.3.2 AI for Clinical and Molecular Diagnostics Market Drivers
2.3.3 AI for Clinical and Molecular Diagnostics Market Challenges
2.3.4 AI for Clinical and Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI for Clinical and Molecular Diagnostics Players by Revenue
3.1.1 Global Top AI for Clinical and Molecular Diagnostics Players by Revenue (2019-2024)
3.1.2 Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global AI for Clinical and Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI for Clinical and Molecular Diagnostics Revenue
3.4 Global AI for Clinical and Molecular Diagnostics Market Concentration Ratio
3.4.1 Global AI for Clinical and Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI for Clinical and Molecular Diagnostics Revenue in 2023
3.5 Global Key Players of AI for Clinical and Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of AI for Clinical and Molecular Diagnostics, Product and Application
3.7 Global Key Players of AI for Clinical and Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI for Clinical and Molecular Diagnostics Breakdown Data by Type
4.1 Global AI for Clinical and Molecular Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Type (2025-2030)
5 AI for Clinical and Molecular Diagnostics Breakdown Data by Application
5.1 Global AI for Clinical and Molecular Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI for Clinical and Molecular Diagnostics Market Size (2019-2030)
6.2 North America AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI for Clinical and Molecular Diagnostics Market Size by Country (2019-2024)
6.4 North America AI for Clinical and Molecular Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI for Clinical and Molecular Diagnostics Market Size (2019-2030)
7.2 Europe AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI for Clinical and Molecular Diagnostics Market Size by Country (2019-2024)
7.4 Europe AI for Clinical and Molecular Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI for Clinical and Molecular Diagnostics Market Size (2019-2030)
9.2 Latin America AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI for Clinical and Molecular Diagnostics Market Size by Country (2019-2024)
9.4 Latin America AI for Clinical and Molecular Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche AI for Clinical and Molecular Diagnostics Introduction
11.1.4 Roche Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Fujifilm
11.2.1 Fujifilm Company Details
11.2.2 Fujifilm Business Overview
11.2.3 Fujifilm AI for Clinical and Molecular Diagnostics Introduction
11.2.4 Fujifilm Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.2.5 Fujifilm Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina AI for Clinical and Molecular Diagnostics Introduction
11.3.4 Illumina Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.3.5 Illumina Recent Development
11.4 GE HealthCare
11.4.1 GE HealthCare Company Details
11.4.2 GE HealthCare Business Overview
11.4.3 GE HealthCare AI for Clinical and Molecular Diagnostics Introduction
11.4.4 GE HealthCare Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.4.5 GE HealthCare Recent Development
11.5 Philips
11.5.1 Philips Company Details
11.5.2 Philips Business Overview
11.5.3 Philips AI for Clinical and Molecular Diagnostics Introduction
11.5.4 Philips Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.5.5 Philips Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic AI for Clinical and Molecular Diagnostics Introduction
11.6.4 Medtronic Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.6.5 Medtronic Recent Development
11.7 Microsoft
11.7.1 Microsoft Company Details
11.7.2 Microsoft Business Overview
11.7.3 Microsoft AI for Clinical and Molecular Diagnostics Introduction
11.7.4 Microsoft Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.7.5 Microsoft Recent Development
11.8 Siemens Healthineers
11.8.1 Siemens Healthineers Company Details
11.8.2 Siemens Healthineers Business Overview
11.8.3 Siemens Healthineers AI for Clinical and Molecular Diagnostics Introduction
11.8.4 Siemens Healthineers Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.8.5 Siemens Healthineers Recent Development
11.9 Intel
11.9.1 Intel Company Details
11.9.2 Intel Business Overview
11.9.3 Intel AI for Clinical and Molecular Diagnostics Introduction
11.9.4 Intel Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.9.5 Intel Recent Development
11.10 Enlitic
11.10.1 Enlitic Company Details
11.10.2 Enlitic Business Overview
11.10.3 Enlitic AI for Clinical and Molecular Diagnostics Introduction
11.10.4 Enlitic Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.10.5 Enlitic Recent Development
11.11 NVIDIA
11.11.1 NVIDIA Company Details
11.11.2 NVIDIA Business Overview
11.11.3 NVIDIA AI for Clinical and Molecular Diagnostics Introduction
11.11.4 NVIDIA Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.11.5 NVIDIA Recent Development
11.12 Qure AI
11.12.1 Qure AI Company Details
11.12.2 Qure AI Business Overview
11.12.3 Qure AI AI for Clinical and Molecular Diagnostics Introduction
11.12.4 Qure AI Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024)
11.12.5 Qure AI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Software
 Table 3. Key Players of Services
 Table 4. Key Players of Hardware
 Table 5. Global AI for Clinical and Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global AI for Clinical and Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global AI for Clinical and Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global AI for Clinical and Molecular Diagnostics Market Share by Region (2019-2024)
 Table 9. Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global AI for Clinical and Molecular Diagnostics Market Share by Region (2025-2030)
 Table 11. AI for Clinical and Molecular Diagnostics Market Trends
 Table 12. AI for Clinical and Molecular Diagnostics Market Drivers
 Table 13. AI for Clinical and Molecular Diagnostics Market Challenges
 Table 14. AI for Clinical and Molecular Diagnostics Market Restraints
 Table 15. Global AI for Clinical and Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global AI for Clinical and Molecular Diagnostics Market Share by Players (2019-2024)
 Table 17. Global Top AI for Clinical and Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI for Clinical and Molecular Diagnostics as of 2023)
 Table 18. Ranking of Global Top AI for Clinical and Molecular Diagnostics Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by AI for Clinical and Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of AI for Clinical and Molecular Diagnostics, Headquarters and Area Served
 Table 21. Global Key Players of AI for Clinical and Molecular Diagnostics, Product and Application
 Table 22. Global Key Players of AI for Clinical and Molecular Diagnostics, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global AI for Clinical and Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Type (2019-2024)
 Table 26. Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Type (2025-2030)
 Table 28. Global AI for Clinical and Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Application (2019-2024)
 Table 30. Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Application (2025-2030)
 Table 32. North America AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America AI for Clinical and Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America AI for Clinical and Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe AI for Clinical and Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe AI for Clinical and Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America AI for Clinical and Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America AI for Clinical and Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Roche Company Details
 Table 48. Roche Business Overview
 Table 49. Roche AI for Clinical and Molecular Diagnostics Product
 Table 50. Roche Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 51. Roche Recent Development
 Table 52. Fujifilm Company Details
 Table 53. Fujifilm Business Overview
 Table 54. Fujifilm AI for Clinical and Molecular Diagnostics Product
 Table 55. Fujifilm Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 56. Fujifilm Recent Development
 Table 57. Illumina Company Details
 Table 58. Illumina Business Overview
 Table 59. Illumina AI for Clinical and Molecular Diagnostics Product
 Table 60. Illumina Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 61. Illumina Recent Development
 Table 62. GE HealthCare Company Details
 Table 63. GE HealthCare Business Overview
 Table 64. GE HealthCare AI for Clinical and Molecular Diagnostics Product
 Table 65. GE HealthCare Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 66. GE HealthCare Recent Development
 Table 67. Philips Company Details
 Table 68. Philips Business Overview
 Table 69. Philips AI for Clinical and Molecular Diagnostics Product
 Table 70. Philips Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 71. Philips Recent Development
 Table 72. Medtronic Company Details
 Table 73. Medtronic Business Overview
 Table 74. Medtronic AI for Clinical and Molecular Diagnostics Product
 Table 75. Medtronic Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 76. Medtronic Recent Development
 Table 77. Microsoft Company Details
 Table 78. Microsoft Business Overview
 Table 79. Microsoft AI for Clinical and Molecular Diagnostics Product
 Table 80. Microsoft Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 81. Microsoft Recent Development
 Table 82. Siemens Healthineers Company Details
 Table 83. Siemens Healthineers Business Overview
 Table 84. Siemens Healthineers AI for Clinical and Molecular Diagnostics Product
 Table 85. Siemens Healthineers Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 86. Siemens Healthineers Recent Development
 Table 87. Intel Company Details
 Table 88. Intel Business Overview
 Table 89. Intel AI for Clinical and Molecular Diagnostics Product
 Table 90. Intel Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 91. Intel Recent Development
 Table 92. Enlitic Company Details
 Table 93. Enlitic Business Overview
 Table 94. Enlitic AI for Clinical and Molecular Diagnostics Product
 Table 95. Enlitic Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 96. Enlitic Recent Development
 Table 97. NVIDIA Company Details
 Table 98. NVIDIA Business Overview
 Table 99. NVIDIA AI for Clinical and Molecular Diagnostics Product
 Table 100. NVIDIA Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 101. NVIDIA Recent Development
 Table 102. Qure AI Company Details
 Table 103. Qure AI Business Overview
 Table 104. Qure AI AI for Clinical and Molecular Diagnostics Product
 Table 105. Qure AI Revenue in AI for Clinical and Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 106. Qure AI Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. AI for Clinical and Molecular Diagnostics Picture
 Figure 2. Global AI for Clinical and Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global AI for Clinical and Molecular Diagnostics Market Share by Type: 2023 VS 2030
 Figure 4. Software Features
 Figure 5. Services Features
 Figure 6. Hardware Features
 Figure 7. Global AI for Clinical and Molecular Diagnostics Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global AI for Clinical and Molecular Diagnostics Market Share by Application: 2023 VS 2030
 Figure 9. Clinical Diagnostics Case Studies
 Figure 10. Molecular Diagnostics Case Studies
 Figure 11. AI for Clinical and Molecular Diagnostics Report Years Considered
 Figure 12. Global AI for Clinical and Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global AI for Clinical and Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global AI for Clinical and Molecular Diagnostics Market Share by Region: 2023 VS 2030
 Figure 15. Global AI for Clinical and Molecular Diagnostics Market Share by Players in 2023
 Figure 16. Global Top AI for Clinical and Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI for Clinical and Molecular Diagnostics as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by AI for Clinical and Molecular Diagnostics Revenue in 2023
 Figure 18. North America AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America AI for Clinical and Molecular Diagnostics Market Share by Country (2019-2030)
 Figure 20. United States AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe AI for Clinical and Molecular Diagnostics Market Share by Country (2019-2030)
 Figure 24. Germany AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Share by Region (2019-2030)
 Figure 32. China AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America AI for Clinical and Molecular Diagnostics Market Share by Country (2019-2030)
 Figure 40. Mexico AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Share by Country (2019-2030)
 Figure 44. Turkey AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE AI for Clinical and Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Roche Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 48. Fujifilm Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 49. Illumina Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 50. GE HealthCare Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 51. Philips Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 52. Medtronic Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 53. Microsoft Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 54. Siemens Healthineers Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 55. Intel Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 56. Enlitic Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 57. NVIDIA Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 58. Qure AI Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2019-2024)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H6022
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart